MedImpact SVP Arpit Patel wins PBMI Innovators Award
SAN DIEGO, CA—August 6, 2026—MedImpact MedImpact, the nation’s largest independent pharmacy benefits and health solutions company, today announced that Arpit Patel, Senior Vice President of Trade Relations and Supply Chain, has received the 2026 Pharmacy Benefit Management Institute® (PBMI) Innovators award.
“This award really belongs to our entire team of clinicians, technologists, and industry experts who come to work every day with a passion to make healthcare work better for the millions of people we serve,” said Arpit Patel, MedImpact Senior Vice President of Trade Relations and Supply Chain. “It is an honor to receive this award, but it is even more rewarding to know we’re making a difference for our clients and members.”
A leading nonprofit organization focused on advancing the pharmacy benefits industry, PBMI helps health plans, employers, and other stakeholders navigate the complex world of pharmacy benefits in pursuit of improved patient outcomes, lower costs, and a better overall healthcare experience.
The PBMI Innovators award recognizes leaders who are implementing cutting-edge pharmacy benefit strategies, contributing fresh insights to the market, and achieving measurable results. Arpit is one of six individuals receiving the award this year.
As a senior leader at MedImpact, Arpit is leveraging more than 20 years in healthcare to improve prescription affordability and access by:
- Offering interchangeable biosimilars that cost 95% less than the reference;
- Delivering a flexible and predictable suite of GLP-1 solutions with built-in lifestyle support;
- Spearheading the development of MedPerform® Flex, MedImpact’s new formulary that lowers costs while preserving access; and
- Reimagining how a pharmacy benefit and health solutions company can partner with and serve clients.
“Healthcare needs to change and Arpit and his team are at the tip of the spear,” said Krista Kelley, MedImpact Chief Commercial Officer, Enterprise. “We are proud to have him as a leader at MedImpact, innovating to improve healthcare for payers and consumers.”
To learn more, read Arpit’s profile in Managed Healthcare Executive print edition or online version.
Biosimilars represent one of the most powerful opportunities to reduce specialty drug costs for payers and members and expand access to effective t
Medication non-adherence is a significant challenge for all healthcare payers but, given its role in CMS Star Ratings, it bears particular weight f

